net_left Kdata Phương Thức Thanh Toán

Moderna signs $35 million deal with cancer drug developer CytomX

06 Tháng Giêng 2023
Moderna signs $35 million deal with cancer drug developer CytomX © Reuters. FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
let atwWrapper,atwContainerWidth,atwSliderBox,atwTotalWidth; function initATWSlider() { atwWrapper = $('.relatedInstruments'); atwSliderBox = atwWrapper.find('.slider'); atwContainerWidth = atwWrapper.width(); atwTotalWidth = atwSliderBox.width(); if(window.domainId === '2' || window.domainId === '3'){ atwWrapper.find('.sliderRight').addClass('js-slider-prev'); atwWrapper.find('.sliderLeft').addClass('js-slider-next'); } else { atwWrapper.find('.sliderRight').addClass('js-slider-next'); atwWrapper.find('.sliderLeft').addClass('js-slider-prev'); } if(atwSliderBox.find('.instrumentBox').length > 6){ atwWrapper.find('.js-slider-next').fadeIn(600); } } function atwMoveRight() { atwWrapper.find('.js-slider-prev').fadeIn(150); $(".slider > :visible:first").hide(150) $(".slider > :visible:last").next().show(150); if(!$(".slider > :visible:last").next().find('.name')()){ atwWrapper.find('.js-slider-next').fadeOut(150); return; } } function atwMoveLeft() { atwWrapper.find('.js-slider-next').fadeIn(150); $(".slider > :visible:last").hide(150); $(".slider > :visible:first").prev().show(150); if(!$(".slider > :visible:first").prev().find('.name')()){ atwWrapper.find('.js-slider-prev').fadeOut(150); return; } } initATWSlider(); //update star icon on adding/removing instrument to/from specific watchlist atwWrapper.on('click', 'label.addRow', function() { let parent = $(this).parent(); let checkedPortfolio = false; parent.find('input[type=checkbox]').each(function () { if($(this).is(':checked')){ checkedPortfolio = true; } }); let closestStar = $(this).closest('.addToPortWrapper').find('.star'); if(checkedPortfolio){ closestStar.addClass('added'); }else{ closestStar.removeClass('added'); } }); //update star icon on creating new watchlist atwWrapper.find('.js-create-watchlist-portfolio').find('a.js-create').on('click',function () { let parent = $(this).parent(); let watchlistName = parent.find('input[type=text]').val(); if(!watchlistName){ return; } let star = $(this).closest('.addToPortWrapper').find('.star'); star.addClass('added'); }); //update star icon on adding new position atwWrapper.find('.js-create-holdings-portfolio').find('.js-submit').on('click',function () { let addPositionForm = $(this).closest('.addToPortfolioPop').find('.holdingsContent'); let amount = addPositionForm.find('.js-amount').val(); if(amount < 1){ return; } let star = $(this).closest('.addToPortWrapper').find('.star'); star.addClass('added'); }); atwWrapper.find('.instrumentBox').find('.shortInfo').on('click',function () { if(!window.ga){ return; } let pairId = $(this).parent().find('.js-add-to-portfolio').attr('data-pair-id'); let pairType = window.atwPairTypes[pairId]; window.ga('allSitesTracker.send', 'event', 'content', 'symbol link clicked', '', { "dimension147":"symbol_link_clicked", "dimension163":"click", "dimension148":"symbol", "dimension162":"content add to watchlist", "dimension161":"article page", "dimension142":"article", "dimension75":pairType, "dimension138":pairId, "dimension118":"2974229" }); window.open($(this).attr('data-href')); }); window.atwPairTypes = {"960580":"Equities","1114321":"Equities"};

(Reuters) - Moderna (NASDAQ:MRNA) Inc on Thursday announced a $35 million licensing deal with cancer-focused drug developer CytomX Therapeutics (NASDAQ:CTMX) to work on messenger RNA-based therapies for a wide range of diseases.

Shares of California-based CytomX rose more than 50% in extended trading.

The firm will get $5 million in prepaid research funding as part of the upfront payment and it is eligible for up to about $1.2 billion in future milestone payments, the companies said in a joint statement.

The news comes a month after an experimental cancer vaccine from Moderna based on mRNA technology was shown to work against a type of skin cancer.

The deal offers CytomX access to Moderna's mRNA technology, which has been used to develop COVID-19 vaccines, while Moderna would get access to CytomX's Probody platform, used in the development of cancer therapies targeting diseased tissues.

Moderna said it will also pay tiered royalties to CytomX on global sales of any products which enter the market under the deal. The agreement also provides the biotech company the option to participate in a future equity financing by CytomX.

The companies will work together to discover experimental therapies and Moderna will be responsible for human trials and commercial activities of products.

An mRNA-based therapy or vaccine works by instructing human cells to produce proteins that can spur the immune system into action.

Để lại bình luận
Hot Auto Trade Bot Phương Thức Thanh Toán
BROKERS ĐƯỢC CẤP PHÉP
net_home_top Ai VIF
21-02-2024 12:44:14 (UTC+7)

EUR/USD

1.0815

+0.0012 (+0.11%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (0)

EUR/USD

1.0815

+0.0012 (+0.11%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (0)

GBP/USD

1.2634

+0.0015 (+0.12%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (6)

Sell (1)

USD/JPY

149.96

-0.03 (-0.02%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (0)

Sell (9)

AUD/USD

0.6571

+0.0023 (+0.35%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

USD/CAD

1.3508

-0.0011 (-0.09%)

Summary

↑ Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (0)

Sell (8)

EUR/JPY

162.20

+0.07 (+0.04%)

Summary

Neutral

Moving Avg:

Buy (11)

Sell (1)

Indicators:

Buy (1)

Sell (3)

EUR/CHF

0.9525

-0.0007 (-0.08%)

Summary

Sell

Moving Avg:

Buy (0)

Sell (12)

Indicators:

Buy (2)

Sell (2)

Gold Futures

2,042.25

+2.45 (+0.12%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (10)

Sell (0)

Silver Futures

23.207

+0.071 (+0.31%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (2)

Copper Futures

3.8747

+0.0169 (+0.44%)

Summary

↑ Buy

Moving Avg:

Buy (11)

Sell (1)

Indicators:

Buy (6)

Sell (0)

Crude Oil WTI Futures

77.37

+0.33 (+0.43%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (8)

Sell (0)

Brent Oil Futures

82.72

+0.38 (+0.46%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (10)

Sell (0)

Natural Gas Futures

1.708

0.000 (0.00%)

Summary

Neutral

Moving Avg:

Buy (7)

Sell (5)

Indicators:

Buy (2)

Sell (3)

US Coffee C Futures

188.03

+1.33 (+0.71%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (9)

Sell (0)

Euro Stoxx 50

4,759.75

-3.32 (-0.07%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (0)

Sell (8)

S&P 500

4,975.51

-30.06 (-0.60%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (1)

DAX

17,068.43

-23.83 (-0.14%)

Summary

Sell

Moving Avg:

Buy (4)

Sell (8)

Indicators:

Buy (1)

Sell (5)

FTSE 100

7,719.21

-9.29 (-0.12%)

Summary

↑ Buy

Moving Avg:

Buy (10)

Sell (2)

Indicators:

Buy (9)

Sell (0)

Hang Seng

16,671.00

+423.49 (+2.61%)

Summary

↑ Sell

Moving Avg:

Buy (1)

Sell (11)

Indicators:

Buy (2)

Sell (5)

US Small Cap 2000

2,003.65

-29.09 (-1.43%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

IBEX 35

10,038.20

+93.40 (+0.94%)

Summary

Sell

Moving Avg:

Buy (5)

Sell (7)

Indicators:

Buy (0)

Sell (5)

BASF SE NA O.N.

46.045

+0.270 (+0.59%)

Summary

↑ Sell

Moving Avg:

Buy (2)

Sell (10)

Indicators:

Buy (0)

Sell (8)

Bayer AG NA

28.77

-0.14 (-0.47%)

Summary

Neutral

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (3)

Sell (3)

Allianz SE VNA O.N.

249.40

+0.75 (+0.30%)

Summary

Sell

Moving Avg:

Buy (6)

Sell (6)

Indicators:

Buy (1)

Sell (7)

Adidas AG

181.12

+1.40 (+0.78%)

Summary

↑ Buy

Moving Avg:

Buy (9)

Sell (3)

Indicators:

Buy (9)

Sell (1)

Deutsche Lufthansa AG

7.339

+0.002 (+0.03%)

Summary

↑ Buy

Moving Avg:

Buy (12)

Sell (0)

Indicators:

Buy (8)

Sell (0)

Siemens AG Class N

168.72

-0.86 (-0.51%)

Summary

Neutral

Moving Avg:

Buy (8)

Sell (4)

Indicators:

Buy (3)

Sell (5)

Deutsche Bank AG

11.954

-0.042 (-0.35%)

Summary

↑ Sell

Moving Avg:

Buy (3)

Sell (9)

Indicators:

Buy (0)

Sell (9)

    EUR/USD 1.0815 ↑ Buy  
    GBP/USD 1.2634 ↑ Buy  
    USD/JPY 149.96 ↑ Sell  
    AUD/USD 0.6571 ↑ Buy  
    USD/CAD 1.3508 ↑ Sell  
    EUR/JPY 162.20 Neutral  
    EUR/CHF 0.9525 Sell  
    Gold 2,042.25 ↑ Buy  
    Silver 23.207 ↑ Buy  
    Copper 3.8747 ↑ Buy  
    Crude Oil WTI 77.37 ↑ Buy  
    Brent Oil 82.72 ↑ Buy  
    Natural Gas 1.708 Neutral  
    US Coffee C 188.03 ↑ Buy  
    Euro Stoxx 50 4,759.75 ↑ Sell  
    S&P 500 4,975.51 ↑ Buy  
    DAX 17,068.43 Sell  
    FTSE 100 7,719.21 ↑ Buy  
    Hang Seng 16,671.00 ↑ Sell  
    Small Cap 2000 2,003.65 ↑ Buy  
    IBEX 35 10,038.20 Sell  
    BASF 46.045 ↑ Sell  
    Bayer 28.77 Neutral  
    Allianz 249.40 Sell  
    Adidas 181.12 ↑ Buy  
    Lufthansa 7.339 ↑ Buy  
    Siemens AG 168.72 Neutral  
    Deutsche Bank AG 11.954 ↑ Sell  
Mua/Bán 1 chỉ SJC
# So hôm qua # Chênh TG
SJC Eximbank7,630/ 7,800
(80/ 50) # 1,762
SJC HCM7,590/ 7,810
(0/ -10) # 1,771
SJC Hanoi7,590/ 7,812
(0/ -10) # 1,773
SJC Danang7,590/ 7,812
(0/ -10) # 1,773
SJC Nhatrang7,590/ 7,812
(0/ -10) # 1,773
SJC Cantho7,590/ 7,812
(0/ -10) # 1,773
Cập nhật 21-02-2024 12:44:16
Xem lịch sử giá vàng SJC: nhấn đây!
ↀ Giá vàng thế giới
$2,031.06 +6.78 0.33%
Live 24 hour Gold Chart
ʘ Giá bán lẻ xăng dầu
Sản phẩm Vùng 1 Vùng 2
RON 95-V24.95025.440
RON 95-III24.16024.640
E5 RON 92-II22.91023.360
DO 0.05S20.99021.400
DO 0,001S-V21.97022.400
Dầu hỏa 2-K20.92021.330
ↂ Giá dầu thô thế giới
WTI $77.29 +3.48 0.05%
Brent $82.01 +3.3 0.04%
$ Tỷ giá Vietcombank
Ngoại tệMua vàoBán ra
USD24.310,0024.680,00
EUR25.830,1527.248,00
GBP30.162,2431.446,11
JPY158,58167,85
KRW15,8919,26
Cập nhật lúc 12:37:11 21/02/2024
Xem bảng tỷ giá hối đoái
Phương Thức Thanh Toán